At the news
? NEUTRALIMPACT 2/10 144 filed Oct 22, 2026 at 16:57 ET
Director Martin J. Gepsman filed a Form 144 notice of intent to sell 400 shares of CME Group common stock, with an approximate market value of $121,000. The sale is small relative to CME's market cap and appears to be a routine diversification move by a director, not a signal of concern.
- Insider: Martin J. Gepsman, Director
- Shares to be sold: 400 shares of common stock
- Estimated value: $121,000
- Shares acquired on 06/25/2026 via restricted stock grant
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access